Patent details
EP1846018
Title:
TARGETED DELIVERY OF BOTULINUM TOXIN FOR THE TREATMENT AND PREVENTION OF TRIGEMINAL AUTONOMIC CEPHALGIAS, MIGRAINE AND VASCULAR CONDITIONS
Basic Information
- Publication number:
- EP1846018
- PCT Application Number:
- PCT/US/2005/047483
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP058559683
- PCT Publication Number:
- WO/2006/083455
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- TARGETED DELIVERY OF BOTULINUM TOXIN FOR THE TREATMENT AND PREVENTION OF TRIGEMINAL AUTONOMIC CEPHALGIAS, MIGRAINE AND VASCULAR CONDITIONS
- French Title of Invention:
- ADMINISTRATION CIBLEE DE TOXINE BOTULINIQUE POUR LE TRAITEMENT ET LA PREVENTION DE CEPHALEES TRIGEMINO-AUTONOMIQUES, DE MIGRAINES ET DE PATHOLOGIES VASCULAIRES
- German Title of Invention:
- GEZIELTE ABGABE VON BOTULINUMTOXIN ZUR BEHANDLUNG UND PRÄVENTION VON TRIGEMINALEN AUTONOMEN CEPHALGIEN, MIGRÄNE UND GEFÄSSERKRANKUNGEN
- SPC Number:
-
Dates
- Filing date:
- 29/12/2005
- Grant date:
- 09/07/2014
- EP Publication Date:
- 09/07/2014
- PCT Publication Date:
- 10/08/2006
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 24/10/2007
- EP B1 Publication Date:
- 09/07/2014
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 29/12/2014
- Expiration date:
- 29/12/2025
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 29/12/2005
-
-
- Name:
- ALLERGAN INC.
- Address:
- 2525 Dupont Drive, Irvine CA 92612, United States (US)
Inventor
- Name:
- Blumenfeld Andrew M.
- Address:
- United States (US)
Priority
- Priority Number:
- 593641 P
- Priority Date:
- 01/02/2005
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
-
A61K 38/48;
Filing date |
Document type |
Number of pages |